Author: Eli Patterson

Whitepaper: Philips Respironics’ DreamMapper

Treatment with PAP therapy is effective, but adherence to treatment is poor. Lower adherence can result in undertreated patients and, in some cases, may lead to refusal of insurers to pay for therapy. DreamMapper is a mobile application and website that employs theoretically driven and empirically tested interventions designed to improve adherence to PAP therapy.

Read More
  • 1
  • 2